Upload
constance-poole
View
216
Download
0
Embed Size (px)
Citation preview
LANGERHAN CELL DISORDERS, PLASMA CELL LESIONS, SPLEEN & THYMUS LESIONS.
By: Dr Jeevan Divakaran.Presenter: Dr Abiodun Mark Akanmode.
LANGERHANS CELL Langerhans cells: immature dendritic cells in the epidermis
Function: to capture antigens and display them to T cells
Express MHC class II antigens, CD1a, and Langerin.
The presence of Birbeck granules in the cytoplasm of langerhan cell is characteristics.
Birbeck granules. Contain protein Langerin. The Birbeck granules are pentalaminar rodlike tubular structures
with a dilated terminal end.(“tennis racket” appearance)
LANGERHANS CELL HISTIOCYTOSES (LCH)
3 distinctive clinicopathologic entities
1. Multisystem LCH (Letterer-Siwe disease)
2. Unifocal unisystem LCH (Eosinophilic granuloma)
3. Multifocal unisystem LCH (Hand-Schüller-Christian disease)
PATHOGENESIS
Different clinical forms are frequently associated with an acquired mutation in the serine/threonine kinase BRAF (valine to glutamate substitution in residue 600) that leads to hyperactivity of the kinase
BRAF is a component of the Ras signaling pathway that drives cellular proliferation and survival
MULTISYSTEM LANGERHANS CELL HISTIOCYTOSIS (LETTERER-SIWE DISEASE)
Children < 2 years
Multifocal cutaneous lesions
Hepatosplenomegaly, Lymphadenopathy, Pulmonary & Osteolytic Lesions
Marrow infiltration - pancytopenia
Rapidly fatal if untreated, but with intensive chemotherapy 50% of the patients survive 5 years
Letterer-Siwe disease - child with eczematous type rash over the body surface due to malignant histiocytes infiltrating the skin and dermis
UNISYSTEM LANGERHANS CELL HISTIOCYTOSIS
May be unifocal or multifocal
Expanding, erosive accumulations of Langerhans cells, within medullary cavities of bones or skin, lungs, stomach
Calvaria, ribs, and femur are most commonly affected
Langerhans cells are admixed with variable numbers of lymphocytes, plasma cells, neutrophils, and eosinophils (may be prominent)
UNIFOCAL UNISYSTEM DISEASE (EOSINOPHILIC GRANULOMA)
Benign histiocytosis mainly in adolescents and young adults
Unifocal lytic lesions in bone (skull, ribs and femur)
Bone pain and fractures are common
Prognosis is excellent
MULTIFOCAL UNISYSTEM DISEASEHAND-SCHÜLLER-CHRISTIAN (HSC) DISEASE
Malignant histiocytosis mainly affecting children
Multiple bony masses that may extend into soft tissues
Hand-Schüller-Christian triad:1. Lytic lesions in Skull2. Diabetes Insipidus3. Exophthalmos
PLASMA CELL LESIONS Multiple Myeloma
Solitary Plasmacytoma/myeloma.
Lympho-plasmacytic Lymphoma
Heavy-chain Disease
Primary Amyloidosis
MGUS
MULTIPLE MYELOMA
Median age at diagnosis - 70 years
More common in males and in people of African origin
Principally involves bone marrow and associated with lytic lesions throughout the skeletal system
Evidence of end-organ damage includes Calcium elevation, Renal insufficiency, Anemia, and Bone lesions (CRAB)
MULTIPLE MYELOMA
Most frequent M protein is IgG (60%), followed by IgA (20% to 25%)
In 15 to 20% cases, the plasma cells produce only κ or λ light chains
Bence-Jones proteins: free κ or λ light chains that are excreted in the urine
PATHOGENESIS OF MYELOMA
Dysregulation of D cyclins is common.
IL-6 produced by fibroblasts, macrophages in the bone marrow stroma stimulates proliferation of myeloma cells.
IL-6 production is also induced by the myeloma cell themselves.
Myeloma Cells secrete IL-1β, TNF, IL-6 which stimulate production of RANK-ligand causing increased osteoclast activity leading to bone resorption
PATHOGENESIS OF MYELOMA
Immunosuppression: Although plasma contains increased immunoglobulin owing to M protein, the levels of functional antibodies are profoundly depressed, leaving patients at high risk for bacterial infections
MORPHOLOGY Multifocal destructive skeletal lesions,
most commonly involving the VERTEBRAL COLUMN, ribs, skull, pelvis, femur, clavicle, and scapula
Punched-out defects 1 to 4 cm in diameter
Arise in medullary cavity, erode cancellous bone, and progressively destroy the cortical bone
Pathologic fractures, mostly in vertebra or femur
Multiple myeloma with multiple vertebral fractures at the thoracic and lumbar levels
MICROSCOPIC EXAMINATION
Increased numbers of plasma cells > 30% of the cellularity
abnormal featuresprominent nucleoli abnormal cytoplasmic inclusions
containing immunoglobulin
In terminal stages, a leukemic picture may
emerge
A
Russell Bodies
CLINICAL FEATURES Pathologic fractures
Bone Pain Vertebral fracture may lead to spinal cord impingement
Hypercalcemia from bone resorption Neurologic manifestations (confusion, lethargy) Renal dysfunction
Symptoms related to hyperviscosity
Anemia: due to marrow replacement by tumor cells and suppression of hematopoiesis
Recurrent infections with bacteria (S. aureus, S.pneumoniae, and E. coli) resulting from the marked suppression
of normal humoral immunity Common cause of death
RENAL FINDINGS
Renal insufficiency (in 50% of patients)
Proteinaceous tubular casts Casts are composed of BJ protein, which is nephrotoxic
and damages tubular epithelium Biopsy reveals an intratubular multinucleated giant cell
reaction
Nephrocalcinosis Hypercalcemia leads to metastatic calcification of the
tubular basement membranes in the collecting ducts Calcium deposits are a common cause of acute renal
failure in multiple myeloma
AL-type amyloidosis (5% to 10% of patients)
DIAGNOSISClinically suspected when focal, punched-out
skeletal defects are present - especially in vertebrae or calvaria
Electrophoresis of the serum and urine - monoclonal complete immunoglobulin or monoclonal free immunoglobulin light chain
Examination of bone marrow: to confirm plasma cell proliferation
SERUM PROTEIN ELECTROPHORESIS • Useful in quantitating the M protein and shows a
monoclonal spike• Does not specify which M protein is increased (e.g., IgG,
IgA, IgM)
OTHER TESTS Serum immunofixation electrophoresis
More sensitive than SPE and provides a characterization of the M protein (heavy and light chain subclass; e.g., IgGκ or IgGλ; IgMκ or IgMλ)
Does not quantitate the M protein
Urine protein electrophoresis Identifies BJ protein (free light chains) and quantitates the amount of
light chains in the urine Does not specify whether the light chains are κ or λ
Urine immunofixation electrophoresis Characterizes whether BJ protein is κ or λ More sensitive in detecting BJ protein than the standard urine protein
electrophoresis
Serum for free light chains Detects and quantitates κ and λ light chains in serum More sensitive for detecting light chains than any of the urine
methodologies listed above
NON-SECRETORY MULTIPLE MYELOMA
In 1 to 3% cases, monoclonal free immunoglobulins can only be detected within the plasma cells
No serum or urine M protein
Bone marrow plasma cells are >10%
CRAB present
TREATMENT AND PROGNOSIS Progressive disease, median survival of around 4
to 6 years
Not curable
Autologous stem cell transplantation - dramatically improved survival
New therapies Proteasome inhibitors (induce plasma cell apoptosis) Thalidomide analogues (alter the marrow
microenvironment to inhibit myeloma cell growth and survival)
SOLITARY PLASMACYTOMA/MYELOMA
Skeletal Plasmacytoma Occurs in same locations as
multiple myeloma Progresses to full-blown multiple
myeloma over 5 to 10 years
Soft tissue Plasmacytoma Most often in upper
respiratory tract Spreads infrequently, cured by
local resection
Low or no serum and urine M proteinNo malignant plasma cells in the bone marrow
LYMPHOPLASMACYTIC LYMPHOMA(WALDENSTRÖM MACROGLOBULINEMIA)
Affects older persons; peak incidence between 6 -7th decades
Tumor cells secrete an M protein (commonly IgM)
Mixture of B cells ranging from small lymphocytes to plasmacytic lymphocytes to plasma cells
Behaves like indolent B cell lymphoma, involves lymph nodes, bone marrow, and spleen at presentation
LYMPHOPLASMACYTIC LYMPHOMA
↑IgM causes viscous blood - Waldenström Macroglobulinemia
No free light chains or Bence Jones proteinuria
No lytic bone lesions
Renal disease and amyloidosis are rare
WALDENSTRÖM MACROGLOBULINEMIA
Visual impairment: tortuosity and distention of retinal veins; retinal hemorrhages and exudates
Neurologic problems - headaches, dizziness, tinnitus, deafness, and stupor, (from sluggish blood flow and sludging)
Bleeding - formation of complexes between macroglobulins and clotting factors as well as interference with platelet function
Cryoglobulinemia - precipitation of macroglobulins at low temperatures -Raynaud phenomenon and cold urticaria
HEAVY-CHAIN DISEASE Not a specific entity
Proliferations in which only heavy chains are produced
IgA heavy-chain disease: more common, has a predilection for lymphoid tissues in which IgA normally is produced (Small intestine, Respiratory tract)
IgG heavy-chain disease: diffuse lymphadenopathy and hepatosplenomegaly
PRIMARY AMYLOIDOSIS
Monoclonal proliferation of plasma cells that secrete free light chains underlies primary amyloidosis
Amyloid deposits (of AL type) consist of partially degraded light chains
MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Asymptomatic monoclonal gammopathy
Serum M proteins in 1 to 3% of healthy persons > 50 years
< 3 g/dL of monoclonal protein in serum No Bence Jones proteinuria
Precursor lesion with a tendency to evolve to multiple myeloma (rate of 1% per year)
Diagnosis made only after careful exclusion of other monoclonal gammopathies, particularly multiple myeloma
POEMS SYNDROME
Paraneoplastic syndrome including
PolyneuropathyOrganomegalyEndocrinopathyMonoclonal gammopathySkin changes
SPLENOMEGALY
Spleenfrequently involved in systemic diseaseresponds by enlarging (splenomegaly)
MASSIVE SPLENOMEGALY (> 1000 G)
Myeloproliferative disorders (CML, Primary Myelofibrosis)
Chronic lymphocytic leukemia and hairy cell leukemia
Lymphomas Malaria Gaucher disease Primary tumors of the spleen (rare)
MODERATE SPLENOMEGALY (WEIGHT 500 TO 1000 G)
Chronic congestive splenomegaly (portal hypertension or splenic vein obstruction)
Acute leukemias (variable)
Hemolytic Anemias (Hereditary spherocytosis, Thalassemia major, Autoimmune hemolytic anemia)
Amyloidosis Niemann-Pick disease Chronic Splenitis (especially with infective endocarditis)
Tuberculosis, Sarcoidosis, Typhoid Metastatic carcinoma or sarcoma
MILD SPLENOMEGALY (<500 G)
Acute splenitis
Acute splenic congestion
Infectious mononucleosis
Miscellaneous: Septicemia, SLE and intra-abdominal infections
HYPERSPLENISM Chronically enlarged spleen removes excessive
numbers of one or more of the formed elements of blood, resulting in anemia, leukopenia, or thrombocytopenia
Most common cause is Portal Hypertension associated with cirrhosis
Platelets are particularly susceptible to sequestration in the interstices of the red pulp
SPLENIC DYSFUNCTION
Howell-Jolly bodies in the peripheral blood RBCs
Predisposition to infections by encapsulated pathogens (septicemia, peritonitis, and osteomyelitis) S. pneumoniae (most common), Haemophilus
influenzae, Salmonella, and Neisseria meningitidis ↓IgM, ↓tuftsin, ↓splenic macrophages
SPLENECTOMY Increases the risk for infections
Hematologic findingsNucleated RBCsHJ bodiesTarget cells (excess membrane cannot be
removed)Thrombocytosis (platelets normally
sequestered in the spleen are now circulating)
THYMIC HYPERPLASIA
Presence of lymphoid follicles/germinal centers in the medulla
Thymic follicular hyperplasia is found in most patients with myasthenia gravis
In other autoimmune diseases – SLE, Rheumatoid arthritis
Removal of hyperplastic thymus is beneficial early in the disease
THYMOMA Tumors of thymic epithelial cells
Classification:
1. Benign or encapsulated thymoma: cytologically and biologically benign
2. Malignant thymomaType I: cytologically benign but infiltrative and locally aggressiveType II (Thymic carcinoma): cytologically and biologically malignant
MORPHOLOGY Lobulated, firm, gray-white masses up to 20 cm
Most appear encapsulated, but in 20% to 25%, penetration of the capsule and infiltration of perithymic tissues and structures are seen
Microscopic: mixture of epithelial tumor cells and non-neoplastic thymocytes (immature T cells)
BENIGN THYMOMA
60-70% of Thymomas
Medullary Thymoma: epithelial cells are spindled or elongated and resemble those that normally populate the medulla
Mixed Thymoma: admixture of the plumper, rounder, cortical-type epithelial cells
MALIGNANT THYMOMA TYPE I 20% to 25% of all thymomas
Cytologically benign but locally invasive
Occasionally metastasize
Varying proportions of epithelial cells and reactive thymocytes
Penetration of the capsule with the invasion of surrounding structures
MALIGNANT THYMOMA TYPE II(THYMIC CARCINOMA)
5% of thymomas
Fleshy, invasive masses, often metastasize (lungs)
Microscopic: most resemble Squamous Cell Carcinoma next most common is Lymphoepithelioma-like
carcinoma (more in Asian populations and sometimes contain the EBV genome)
CLINICAL FEATURES Rare
Mostly in middle-aged adults 30% asymptomatic 30% to 40% produced local manifestations (cough,
dyspnea, and superior vena cava syndrome) 30% associated with a systemic disease
most commonly myasthenia gravis (Thymoma in 15 to 20% patients)
Additional associations: Hypogammaglobulinemia, Systemic Lupus Erythematosus, Pure Red Cell Aplasia and Non-Thymic Cancers